投资1.3亿元、面积约6000平方米，西南最大细胞治疗专业化实验室按下建设“快进键”

Core Insights - The construction of the largest specialized cell therapy laboratory in Southwest China is entering a critical phase, with a total investment of 130 million yuan and an area of approximately 6,000 square meters, set to be completed by July next year [1][5]. Group 1: Laboratory Development - The laboratory is being built according to GMP standards and will serve as a crucial infrastructure for the cell therapy field in Southwest China, supporting the full chain development from laboratory to commercialization [3][5]. - The project is a key component of the national "two重" project, receiving significant policy support, including funding from the National Development and Reform Commission [5][6]. - The design of the laboratory allows for flexible expansion, catering to the needs of future resident companies, which will lower the research and development barriers for startups [5][6]. Group 2: Industry Ecosystem - The cell therapy industry in Chengdu is rapidly forming an innovative ecosystem, bolstered by strong local medical resources and government support [6]. - The project has benefited from comprehensive policy support, including land assurance, financial assistance, and talent cultivation [6]. - The park is attracting various companies in the cell and gene therapy sectors, fostering collaboration in technology research, clinical applications, and industrialization [6].